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“The moment you doubt whether you can fly, 
you cease for ever to be able to do it.” 
 
J.M. Barrie, Peter Pan 
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Abstract 
Bracken fern (Pteridium aquilinum) is one of the most abundant and widely distributed 
plant species worldwide and has been associated with a variety of health problems in humans, 
namely cancer, and animals since the XIX century. Bracken has the ability to endure insect 
attacks, microorganisms and unfavourable weather. This, coupled with its aptitude to spread, 
made it necessary to focus considerable efforts on its control and on understanding its toxicity. 
About 100 metabolites have been isolated from bracken; of these, ptaquiloside, an unstable 
sesquiterpene glycoside, is the one responsible for most of the fern’s carcinogenicity. 
Studies on the toxicological effects that ptaquiloside has on animals and, potentially, on 
humans are dependent of its isolation from the plant. At LEPABE efforts are being made to 
develop a faster and more efficient method for the ptaquiloside isolation from Pteridium 
aquilinum. 
A key aspect for implementing these methods and assessing their efficiency is the 
quantification of ptaquiloside present in the plant and the amount obtained by the isolation 
method, as well as during the stages of the procedure. Thus, it becomes necessary to develop 
an appropriate method for ptaquiloside quantification. 
The objective of this work was to develop, validate and implement a fast, simple and 
optimized HPLC method to quantify the content of ptaquiloside during the extraction 
procedure. 
By applying a conversion methodology, quantification of ptaquiloside in bracken samples 
was possible, monitor the concentration/clean-up step of ptaquiloside isolation and identify 
some unnecessary stages, expediting the isolation process and therefore reducing the loss of 
ptaquiloside due to hydrolysis. 
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1. Introduction 
Bracken fern (Pteridium aquilinum (L.) Kuhn) is one of the most abundant and widely 
distributed plant species worldwide (Alonso-Amelot et al. 1993; Castillo et al. 1998; Pathania 
et al. 2012) and has proven itself to be a very resilient plant (Davis et al. 2013). Bracken can 
be found in most ecosystems (Alonso-Amelot et al. 1993; Dawra et al. 2002; Rasmussen et al. 
2005) and has been associated with a variety of health problems in humans and animals since 
the XIX century (Agnew & Lauren 1991; Castillo et al. 1998). Pteridium aquilinum is classified 
as carcinogenic for animals and possibly carcinogenic for humans (2B group) by the International 
Agency for Research on Cancer (IARC) (Somvanshi & Ravisankar 2004; Rasmussen et al. 2005; 
Gil da Costa 2011). 
 
 
Figure 1 - Mature bracken (Pteridium aquilinum) plants at Arcos de Valdevez, 
Portugal. Removed from (Gil da Costa 2011) 
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1.1. Pteridium aquilinum 
Bracken is a perennial fern (Whitehead & Digby 1997) that grows in the mountainous areas 
of the tropics and in the temperate regions of the world (Alonso-Amelot et al. 1992a; Wilson et 
al. 1998) in a wide diversity of climates and soil types (Davis et al. 2013). In fact, it grows in 
all continents (except Antarctica) (Hojo-Souza et al. 2010) and can be found most often at 
forest margins, in recently deforested areas, abandoned agricultural regions (Smith & Seawright 
1995), on clear-cut or newly burned areas and in glades (Rasmussen 2003). 
P. aqulinum is normally found on well-drained acid soils (from pH 2.6), but may at times be 
encountered at nutrient rich and even calcareous soils (up to pH 7.5) (Rasmussen 2003). 
The species Pteridium aquilinum belongs to the Pteridium genus and to the 
Dennstaedtiaceae family (Cruz & Bracarense 2004; Der & Thomson 2009). Bracken ferns are 
easily distinguished from other genera in Dennstaedtiaceae, and several taxa within this genus 
are attributed according to the morphological structure associated with their geographical 
location (Der & Thomson 2009). In Table 1 the classification of the genus Pteridium is described. 
 
Table 1 - Genus Pteridium classification; where 2n=diploid number of chromosomes. Adapted from 
Hojo-Souza et al. 2010 
Species Sub-Species Occurrence 
Pteridium aquilinum (L.) Kuhn 
Diploid strain (2n=104) 
latiusculum North America 
pinetorum Europe 
japonicum Asia 
capense Sub-Saharan Africa 
aquilinum Europe 
wightianum 
India, Southeast Asia and 
Northern Australia 
decompositum Hawaii 
centrali-africanum Sub-Saharan Africa 
pseudocaudatum Eastern North America 
pubescens North America 
feei Central America 
Pteridium esculentum (G. Forst.) Cockayne 
Diploid strain (2n=104) 
 
South Hemisphere 
(Australia) 
Pteridium arachnoideum (Kaulf.) Maxon 
Diploid strain (2n=104) 
 
South Hemisphere (South 
America) 
Pteridium caudatum (L.) Maxon 
Allotetraploid strain (4n=208) 
 
Southern and Central 
America 
Pteridium semihastatum (Wall. Ex J. 
Agardh) S. B. Andrews 
Allotetraploid strain (4n=208) 
 
South-East Asia and 
Northern Australia 
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The genus Pteridium can be divided into five species: P. aquilinum, P. esculentum, P. 
arachnoideum, P. caudatum and P. semihastatum (Hojo-Souza et al. 2010; Thomson 2004). 
Along with this classification, these ferns can be grouped according to their morphology and 
genetic characteristics, which are associated with their geographical location. The diploids 
species P. arachnoideum and P. esculentum can be found in the Southern hemisphere and can 
be genetically and morphologically distinguished from the northern hemisphere bracken, P. 
aquilinum. Additionally, the allotetraploid P. caudatum is characteristic of Southern and 
Central America, whereas the P. semihastatum is mostly present in South-East Asia and 
Australia (Thomson 2004). 
 
1.2.  Pteridium aquilinum Morphology and Biology 
Bracken fern efficiently competes for light, soil nutrients and water with other species 
(Dolling et al. 1994), due to the plant’s rhizome system (horizontal underground stems) that 
can spread underneath the roots of other vegetation and sprout fronds preventing sunlight from 
reaching those plants (Davis et al. 2013). Rhizomes function as a storage organ for nutrients 
and, by advancing through the soil, also benefit colonisation. The plant dies in autumn, growing 
again from the rhizome in spring as a crozier that slowly straightens as it develops. Bracken 
also can spread and colonise as result of the release of spores that can travel hundreds of 
kilometres and colonise other areas (Fenwick 1988; Cruz & Bracarense 2004). 
P. aquilinum possesses an erect, rigid stalk with large triangular blades (Fenwick 1988). 
Mature fronds can grow between 0.6 to 1.8 meters, but can reach 3 meters depending on the 
environment (Davis et al. 2013) and may reach maximum length in a few months (Rasmussen 
2003), also, in colour, the fronds vary from yellowish-green to dark green (Shahin et al. 1999). 
This plant can reach the mature stage in only 60 to 70 days (depending on its location), 
becoming a source of food for herbivores, mainly during the dry season when other plants 
become scarce (Alonso-Amelot et al. 1992a; Rasmussen 2003), possessing a dry matter 
production of 1.400 g/m2 (Rasmussen 2003). 
 
1.3. Pteridium aquilinum Toxicity 
Bracken has the ability to resist insect attacks, microorganisms and unfavourable weather 
(Alonso-Amelot & Avendaño 2002) which coupled with its aptitude to spread, makes it necessary 
to dedicate great efforts on its control and on understanding its toxicity. 
Since the end of the XIX century, the ingestion of the plant by cattle was associated with 
the presence of haematuria and others disorders (Yamada et al. 2007). Nonetheless, only in 
1965, Evans and Mason, were able to induce tumours in rats fed with bracken (Evans & Mason 
1965), thus proving its carcinogenicity. Since then, bracken has been intensively studied 
biologically and chemically, to assess animal susceptibility to this plant. 
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Bracken fern is the only plant known to naturally cause cancer in animals (Smith & Seawright 
1995; Rasmussen 2003). This plant is the cause of various diseases in cattle, sheep, horse and 
other farm and laboratory animals (Alonso-Amelot et al. 1992a). The ingestion of bracken can 
cause thiamine deficiency (Hojo-Souza et al. 2010), bovine enzootic haematuria (BEH) (Hopkins 
1990; Alonso-Amelot et al. 1992a), bladder and intestinal carcinomas in cattle (Oelrichs et al. 
1995; Potter & Baird 2000) and liver, kidney, urinary bladder, mammary gland and intestine 
carcinomas in rats and mice (Alonso-Amelot et al. 1992a; Oelrichs et al. 1995). 
In addition to the direct ingestion of bracken, the inhalation of its spores and consumption 
of milk produced by cattle exposed to bracken may be responsible for stomach and oesophageal 
cancer in humans (Alonso-Amelot et al. 1992a; Oelrichs et al. 1995; Rasmussen et al. 2013). 
The concentration of toxic bracken compounds varies with the age and the plant section. 
The major amount of carcinogenic substances can be found in bracken croziers (Yamada et al. 
2007). 
 
1.4. Ptaquiloside 
About 100 metabolites have been isolated from bracken and of these, ptaquiloside (Pta) 
(Alonso-Amelot et al. 1992a), an unstable norsesquiterpene glycoside of the illudane type 
(Yamada et al. 1998), is the one responsible for most of the fern’s carcinogenicity (Alonso-
Amelot et al. 1992a; Oelrichs et al. 1995). Ptaquiloside (Figure 2) was characterised and 
independently isolated by two groups: one in Japan (Niwa et al. 1983) and other in The 
Netherlands (Van der Hoeven et al. 1983) in 1983. 
 
CH
3
CH
3
OH O
CH
3
O
OH
OH
OH
O
OH
 
Figure 2 – Ptaquiloside chemical structure. 
 
Ptaquiloside is an amorphous compound, colourless, with the molecular formula C20H30O8 
(Niwa et al. 1983) and chemical name [2’R-(2’α,3’aα,4’β,7’aα)]- 7’a-(β-D- glucopyranosyloxy)-
1’,3’,a,4’,7’a- tetrahydro-4’-hydroxy-2’,4’,6’-trimethyl- spiro[cyclopropane-1-5’-[5H]inden]- 
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3’(2’H)-one (Rasmussen 2003). It is stable at room temperature only for a week but remains 
stable for six months at low temperatures (from 0°C to -20°C) (Yamada et al. 2007). In aqueous 
solutions, ptaquiloside is gradually converted into pterosin B (PtB) and D-glucose, at a rate 
dependent of the solution’s pH (Yamada et al. 1998). 
 
Table 2 - Physical and chemical properties of ptaquiloside. 
Property  Reference 
Molecular Formula C20H30O8 (Niwa et al. 1983) 
Molecular Weight 398.45 g/mol (Rasmussen 2003) 
Melting Point 85-89ºC (Saito et al. 1990) 
UV absorption maxima 214; 220 nm (Saito et al. 1989) 
 
Ptaquiloside rapidly loses its glucose moiety creating an unstable intermediary - 
pteridienone, a strong electrophile capable of alkylating amino acids and DNA (Alonso-Amelot 
et al. 1993; Fletcher et al. 2011; Jensen et al. 2008; Yamada et al. 1998). In Figure 3 are 
represented the hydrolysis reactions of ptaquiloside, which is unstable in acid and basic 
conditions (Agnew & Lauren 1991). In alkaline conditions, ptaquilosin is formed and this one 
leads to the unstable pteridienone; in acidic conditions, both ptaquiloside and the pteridienone 
form pterosin B (Alonso-Amelot et al. 1995; Rasmussen et al. 2005). Pterosin B is stable under 
both acid and alkaline conditions, while ptaquilosin and the pteridienone are only stable under 
alkaline conditions (Van der Hoeven et al. 1983; Niwa et al. 1983). 
Ptaquiloside is soluble in water and it has been reported that it is clastogenic (causes 
structural damages to chromosomes), mutagenic (causes genetic mutations) and teratogenic 
(leads to modifications in the embryonic structure) (Ayala-Luis et al. 2006; Pathania et al. 
2012). Its elevated toxicity is associated with the electrophilic properties of the unstable three 
carbon ring (cyclopropyl group), which alkylates a wide variety of nucleophiles (biomolecules 
such as nucleotides) (Alonso-Amelot et al. 1993; Yamada et al. 1998; Bonadies et al. 2004). 
Nevertheless, anti-tumour activity and cytotoxicity to cancer cells has been described (Zhao 
2011). 
As stated above, after ptaquiloside loses its glucose moiety, the ptaquiloside aglycone 
converts to a strongly electrophilic cyclopropane pteridienone that reacts towards various weak 
nucleophiles like water, amines and other mild bases. Additionally, ptaquiloside is capable of 
penetrating the cell and nucleus membranes (Alonso-Amelot et al. 1993) since its aglycone 
fragment allows solubility in chloroform, methylene chloride, acetonitrile and methanol, while 
the glucose portion enables dilution in water (Alonso-Amelot & Avendaño 2002). 
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Figure 3 - Reactions of ptaquiloside. 
 
For the activation of ptaquiloside (conversion to pteridienone) there is no need for 
metabolic activation, since the pteridienone formation is only pH dependent (Yamada et al. 
1998). As mentioned before, ptaquiloside loses its glucose moiety under alkaline conditions to 
originate ptaquilosin and afterwards pteridienone is formed which is transformed into an 
aromatic compound, pterosin B. The prerequisite of alkaline conditions for the activation of 
ptaquiloside is reinforced by biological observations, since induced tumours of the bovine 
oesophagus and bladder are associated with environments of pH 8.1-8.2 and 7.5-8.5, 
respectively (Fenwick 1988; Saito et al. 1989). In rats, P. aquilinum mostly induces tumours of 
the terminal section of the ileum, a segment with the highest pH in the intestine (Price & 
Pamukcu 1968; Shahin et al. 1998). 
When in contact with physiological nucleophiles, like purine bases in uncoiled DNA, the 
pteridienone will promote a DNA alkylation that may disrupt gene transcription (Figure 4) 
(Alonso-Amelot & Avendaño 2002). DNA cleavage occurs through a reaction between DNA and 
pteridienone to form adducts through the N-3 of adenine and/or N-7 of guanine (Yamada et al. 
2007). Its DNA-cleaving potential combined with potentially high biological uptake and mobility 
due to the glucose moiety, are likely responsible for the carcinogenicity and toxicity of 
ptaquiloside (Rasmussen 2003). 
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Figure 4 - DNA alkylation via pteridienone; squares represent pyrimidine bases and rectangle represent 
purine bases. Adapted from (Alonso-Amelot & Avendaño 2002). 
 
The pteridienone causes a permanent change in the genes attacked. These genes may 
regulate the activation of other genes or have regulatory functions of multiple biochemical and 
cellular processes (Alonso-Amelot & Avendaño 2002), such as the p53 gene which regulates cell 
proliferation, DNA repair, apoptosis and tumour suppression. Thus, DNA alkylation by the 
pteridienone is considered to be the basis of bracken-induced carcinogenesis (Cruz & 
Bracarense 2004). 
The administration of ptaquiloside to animals causes acute poisoning, blindness and 
tumours (Dawra et al. 2002; Rasmussen et al. 2005; Gil da Costa 2011), depending on the intake 
dose and on the animal species. Other possibility is the contamination of ground water, since 
ptaquiloside can be washed by rain and subsequently contaminate the soil and ground waters 
(Jensen et al. 2008). 
In bracken, the concentration of some sesquiterpenoids has been known to vary significantly 
along the growing season and to be dependent on the plant compartment (Hojo-Souza et al. 
2010). Ptaquiloside concentrations of up to 4.450 mg/g in dry weight basis in mature fronds 
have been reported (Rasmussen 2003). It is known that ptaquiloside appears in higher 
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concentration in the crozier than in the mature frond (Yamada et al. 2007), which combined 
with the fern availability increases the risk of animal poisoning (Alonso-Amelot et al. 1992a; 
Alonso-Amelot et al. 1993). 
 
1.5. Human exposure to Pteridium aquilinum 
Over the centuries, the use of Pteridium aquilinum as human food has been described, 
mostly in times of food shortage, like during the First World War – a sort of flour was made out 
of the rhizomes. The fronds have also been used as bedding for animals, floor cover, fuel, as 
ornamental and ritual plant, as bleaching and dying agent, for dykes, roofing, baskets, mulch 
and compost (Rasmussen 2003). Nevertheless, in Canada, parts of the United States of America, 
China and specially, Japan, bracken fern is grown commercially for human use, as food or herbal 
remedy (Fenwick 1988). The raw fern is usually processed in some manner, e. g. with boiling 
water and soda ash treatment, which reduces the carcinogenic activity (Smith & Seawright 
1995; Fenwick 1988). 
Indirect contact with ptaquiloside may also occur. Evans et al. and Alonso-Amelot et al. 
reported the discovery of this carcinogenic principle in milk and meat from animals that feed 
on bracken (Evans et al. 1972; Alonso-Amelot et al. 1993; Recouso et al. 2003; Fletcher et al. 
2011) and in 1988, it was stated that rain might leak carcinogens from the plant and eventually 
passage them to water supplies (Fenwick 1988). Additionally, the inhalation of bracken spores 
can expose humans to the toxic effects of bracken fern (Potter & Baird 2000). 
The contact with bracken by humans has been associated with a greater occurrence of 
upper oesophageal carcinoma (Smith & Seawright 1995), stomach cancer (Alonso-Amelot & 
Avendaño 2001) and respiratory neoplasias (breathing of spores) (Alonso-Amelot & Avendaño 
2002) (Figure 5). 
The results of the animal tests are quite conclusive, demonstrating the carcinogenicity of 
bracken in general and of ptaquiloside in particular. The evidence for human cancer is less 
conclusive, although studies indicate higher abundance of cancer in areas with bracken 
abundance. These studies should be treated with caution as they include very small populations 
(Wilson et al. 1998; Brown et al. 1999). Nevertheless, Marliére et al. showed a significant higher 
occurrence of oesophageal cancer among people eating bracken than people not ingesting 
bracken (Marliére et al. 2002). 
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1.6. Main Objective 
Studies of the toxicological effects of ptaquiloside on animals and, potentially, on humans 
are dependent on ptaquiloside isolation from the fern. However, the available isolation 
methods are extremely time-consuming and present low efficiency. At LEPABE (Laboratory for 
Process Engineering, Environment, Biotechnology and Energy) efforts are being made to 
develop a faster and more efficient method for the isolation of ptaquiloside from P. aquilinum. 
A key aspect for the implementation of these methods and assess their efficiency is the 
quantification of ptaquiloside present in the plant and the quantity obtained by the isolation 
method, as well as during the stages of the procedure. Thus, the development of an appropriate 
method for ptaquiloside quantification becomes necessary. The present work aimed to develop 
such a method, in the context of the ongoing research at LEPABE. 
 
Bracken Ingestion 
Ptaquiloside 
 
Pteridienone 
Uncoiled DNA 
Coiled DNA 
DNA alkylation 
DNA Fragmentation 
DNA 
Faulty Transcription 
Cancer 
Other protein 
malfunctioning 
 
Figure 5 - Consequences of bracken ingestion. Adapted from (Alonso-Amelot & Avendaño 2002). 
DNA Depurination 
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2. State of the Art 
The global economic importance of Pteridium aquilinum, due to its abundance, its toxicity 
to animals and potential affect to human health through production of carcinogens (McGlone 
et al. 2005), has resulted in extensive scientific literature, most of which with the objective of 
isolating ptaquiloside. According to the objectives of this work, the literature review will only 
focus on the quantification methods of ptaquiloside. 
Throughout the years, a variety of methods were developed with the objective of 
quantifying ptaquiloside, as described in the Appendix. The majority of these methods are 
based on the one originally developed by Agnew & Lauren (1991). 
Due to the extremely unstable nature of the compound, direct analysis is problematic. Also, 
treatments with acid, base, light or heat should be evaded in the clean-up steps of the analysis 
(Saito et al. 1989). Additionally, ptaquiloside content in bracken can vary greatly with species, 
growth stage, altitude and within stands grown in analogous conditions (Ramwell et al. 2010). 
As a result of ptaquiloside degradation by heat, it is of extreme importance the use of fresh 
frond material without drying, in order to obtain the best yields of this compound (Alonso-
Amelot et al. 1992b). 
 
2.1. Quantification Methods 
Firstly, in 1987 a modified mutagenicity test was applied to quantify ptaquiloside in the 
crude extract of Pteridium aquilinum (Matoba et al. 1987). In 1989, a new method of 
quantification was applied, using thin layer chromatography (TLC) coupled with 
photodensitometry (Saito et al. 1989). This technique is based on the ptaquiloside instability, 
since the sample was applied on a TLC plate at 110ºC during 2 hours, allowing ptaquiloside to 
convert into pterosin B. Nonetheless, TLC was inadequate for ptaquiloside quantification, since 
the complete transformation of ptaquiloside and the single production of pterosin B were not 
established (Alonso-Amelot et al. 1992a).  
High pressure liquid chromatography (HPLC) offered higher sensitivity over TLC for the 
quantification of ptaquiloside and pterosin B (Alonso-Amelot et al. 1992b). In this work of 1992, 
Alonso-Amelot and co-workers successfully applied high pressure chromatography for the 
quantification of ptaquiloside and pterosin B. They were able to produce a good compound 
separation and using a mobile phase of CH3OH:H2O (65:35, v/v) it was possible to obtain 
retention times around 10 minutes for pterosin B (Alonso-Amelot et al. 1992b). 
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In 2004, Bonadies et al. 2004 suggested the advantages of using gas chromatography-mass 
spectrometry (GC-MS) to analyse trace amounts of ptaquiloside in a complex mixture as a 
bromo-compound derived from ptaquiloside. The bromo-compound is exclusively derived from 
ptaquiloside, so the advantage of quantifying this compound instead of pterosin B is that it does 
not exist in the original sample, so it is not necessary to perform the initial analysis of the 
sample (Bonadies et al. 2004). 
In the Appendix, only quantification methods of ptaquiloside are described. HPLC is the 
most used method in literature (Ayala-Luis et al. 2006). Although ptaquiloside can be directly 
quantified (at 220 or 214 nm), a recurring method is to convert ptaquiloside into pterosin B, 
through a base-acid treatment, following by analysis at 214, 220 or 260 nm (Jensen et al. 2008) 
due to ptaquiloside’s instability (Rasmussen 2003; Yamada et al. 2007). This treatment is also 
preferred to the heat treatment due to its mildness (pH 11.5, 40 ºC) and completeness within 
a short period of time (Alonso-Amelot et al. 1992a). Also the UV response is duplicated, lowering 
the detection limit (Jensen et al. 2008) and allowing the determination of low levels of 
ptaquiloside (Agnew & Lauren 1991). 
Agnew & Lauren (1991) also studied the reaction conditions required to convert ptaquiloside 
to pterosin B in either acid or basic conditions (Figure 6). In the first case, they discovered that 
this reaction gave two or more products, while the second only converted ptaquiloside to the 
pteridienone followed by acidic treatment to yield pterosin B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Passage through a polyamide resin 
1 mL of eluate + 75 µL/mL of NaOH 1M 
1 h at 40°C 
Add 75 µL/mL of HCl 5M  
Sample Clean-up 
Ptaquiloside conversion to 
Pterosin B 
Bracken Aqueous Extract 
Figure 6 - Representation of Agnew and Lauren (1991) conversion method. 
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The method chosen by Agnew & Lauren (1991) adds sodium hydroxide (NaOH) to the sample 
and, after the reaction occurs, adds hydrochloric acid (HCl). However, a modified method is 
now preferred, because HCl can produce unwanted chloro-analogues, so HCl is substituted by 
sulphuric acid (H2SO4) (Fletcher et al. 2011; Bonadies et al. 2011). Nevertheless, this method 
only decreases the concentration of chloro-analogues, since the chloride ion is naturally present 
in the plant and acts as nucleophile to give the chloro-derivative in a significant yield (Bonadies 
et al. 2004). 
The purpose of the clean-up step is to remove all pterosin B present in the sample extract, 
by passing it through a polyamide resin, in order to only quantify the pterosin B obtained by 
ptaquiloside conversion (Agnew & Lauren 1991; Jensen et al. 2008; Rasmussen et al. 2013). 
Alternatively to this clean-up step, an initial analysis of the sample can be performed to assess 
the quantity of pterosin B present in the plant due to light-induced decomposition of 
ptaquiloside (Alonso-Amelot et al. 1992a). The difference between pre- and post-conversion 
values corresponds to pterosin B formed from ptaquiloside during the conversion step. 
As described in Table 3, the majority of researchers preferred the quantification by HPLC, 
although some use different types of detectors, as ultraviolet detector or a combination of 
ultraviolet with visible light. Several studies used acetonitrile in water or a methanol in water 
gradient as the mobile phase (Alonso-Amelot et al. 1993; Rasmussen et al. 2013), these being 
the majority of mobile phases used in ptaquiloside and pterosin B quantification. 
In the literature, some reports used mass spectrometry (MS), because substances with a 
similar retention time and UV-VIS spectrum may be misidentified as the compound in question. 
As a result, there is a risk for false positive as well as negative analytical results using unspecific 
detection, such as UV-VIS. Mass spectrometric detection is preferable because it provides the 
required specificity and a lower limit of detection (Jensen et al. 2008). As previously 
mentioned, some authors also use GC-MS for ptaquiloside quantification, after conversion to 
pterosin B (Bonadies et al. 2004). 
Throughout the years, researchers have analysed samples of bracken fern from around the 
world and quantified their ptaquiloside content. In Table 4, the ptaquiloside concentrations 
are summarized. 
Ptaquiloside content in fronds of different varieties of bracken varies between 0 and 15.1 
mg/g (Rasmussen 2003). Although there seems to be no significant differences between 
varieties (Smith et al. 1994), the genetic inheritance can impact  the ptaquiloside content once 
different proveniences still have different ptaquiloside contents when grown under the same 
conditions (Smith et al. 1994; Rasmussen, Kroghsbo, et al. 2003). Ptaquiloside content is usually 
at is maximum just after the croziers arise from the ground and the content decreases 
progressively during growth season (Rasmussen 2003). 
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Table 3 - Main characteristics for Pta/PtB HPLC quantification. 
Reference 
Pta/PtB Quantification 
Detector Column Mobile Phase 
Agnew & 
Lauren 1991 
UV 
ODS 5 µm or C8 (25 cm x 4.6 
mm I. D.), RP-8 guard column 
H2O: CH3OH (60:40, v/v) for Pta 
H2O: CH3OH (40:60, v/v) for PtB 
Alonso-
Amelot et al. 
1993 
UV-VIS C-18 Radial 0.5 x 10 cm CH3OH:H2O (65:35, v/v) in the isocratic mode 
Dawra et al. 
2002 
UV-VIS 
C-18 Reverse-phase 
(4.6 x 250 mm) 
C2H3N:H2O gradient 
(20:80, v/v for first 20 min followed by 
increase to 100% acetonitrile in the next 20 
min) 
Rasmussen 
2003 
UV-VIS 
RP-8, 5 µm (125 x 4 mm) and 
4x4 mm I.D. RP-18e, 5 µm 
safe guard column 
H2O: C2H3N gradient 
Rasmussen 
et al. 2005 
UV-VIS 100 RP-8, 4 µm (125 x 4 mm) 
MillQ-H2O: C2H3N (92:8, v/v) for Pta 
Double deionised H2O: C2H3N (83:17, v/v) for 
PtB 
Ayala-Luis et 
al. 2006 
UV-VIS 
100 RP-8, 4 µm (125 x 4 mm), 
safe guard column 100 RP-
18e, 4 x 4 mm 
Isocratic mode: C2H3N: H2O (18:82, v/v) 
Gradient mode: start with the isocratic mode 
and after 10 min, a gradient was applied 
until reaching C2H3N: H2O (55:45, v/v) 
Latorre 2010 UV 
ODS (4 mm x 150 mm, 
Shimadzu), C18 reverse phase 
safe guard column 
H2O: CH3OH: 40% CH3OH (0-2 min); 40-80% 
CH3OH (2-15 min);80-40% CH3OH (15-16 
min);40 CH3OH (16-25 min) 
Fletcher et 
al. 2011 
UV-Vis 
C18 column 250 x 4.6 mm, 5 
µm 
Mixture of (A) 40:60 C2H3N in water (v/v) and 
(B) C2H3N with a gradient as follows: 0-9 min, 
held at 100% A; 9-11 min, 100% A-100% B; 11-
16 min, held at 100% B; 16-16.5 min, 100% B-
100% A; 16.5-25 min, held at 100% A. 
Rasmussen 
et al. 2013 
UV-VIS 100 RP-8, 4 µm (125 x 4 mm) H2O: C2H3N (69:31, v/v) 
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Table 4 - Ptaquiloside content in Pteridium aquilinum. 
Reference Country Sample Pta content 
Saito et al., 1989 Japan 
Fronds 0.02 – 0.14 % dry weight 
Rhizomes 0.03 – 0.12 % dry weight 
Agnew & Lauren 
1991 
New 
Zealand 
Bracken Fern 0.03 mg/g – 4 mg/g dry weight 
Alonso-Amelot et 
al. 1992b 
Venezuela 
Large fronds 
1.9 mg/g 
Young croziers 
Smaller or mature 
fronds 
0.07 mg/g 
Alonso-Amelot et 
al. 1992a 
Venezuela 
Crozier 1.6 mg/g 
Mature Frond 0.113 mg/g 
Rhizomes 0.0046 mg/g 
Smith et al. 1994 Australia 
Pteridium samples 
from around the 
world 
0 – 9.776 mg/kg 
Castillo et al. 1998 Venezuela Fresh fronds 0.007 mg/g 
Rasmussen 2003 Denmark Mature fronds 0.110 – 4.450 mg/g dry weight 
Rasmussen, 
Kroghsbo, et al. 
2003 
Denmark Mature Fronds 0.108 – 3.795 mg/g 
Rasmussen, 
Jensen, et al. 2003 
Denmark 
Fronds 0.213 – 2.145 mg/g 
Rhizomes 0.011 – 0.902 mg/g 
Rasmussen et al. 
2013 
Denmark Spores Maximum of 0.029 mg/g 
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3. Materials and Methods 
3.1. Overall Methodology 
The aim of this work was to quantify the ptaquiloside content in bracken fern samples and 
in samples obtained throughout ptaquiloside isolation process. 
As stated before, ptaquiloside analysis is challenging due to the extremely unstable nature 
of the compound. On the other hand, this feature can be used to develop an indirect 
quantification method based on the ptaquiloside conversion to pterosin B. Pterosin B is present 
in the plant due to light-induced decomposition of ptaquiloside and with this method pterosin 
B concentration is increased, taking advantage of ptaquiloside instability in water, acid and 
base. 
Ptaquiloside quantification will be carried out by calculating the difference between the 
initial content of pterosin B in the samples and the content present after ptaquiloside 
conversion to pterosin B. 
Thus, the implementation of pterosin B quantification chromatographic conditions and the 
validation of HPLC quantification of pterosin B was performed. Afterwards, ptaquiloside 
conversion to pterosin B was implemented, as well as the validation of the ptaquiloside 
quantification method, employing samples obtained from previous work (Gil da Costa 2011). 
Ultimately, this quantification method was used to monitor a new cycle of ptaquiloside 
isolation, allowing a faster and more efficient processing of bracken samples. 
 
3.2. Bracken Samples 
The research carried out in this work focused on the bracken variety Pteridium aquilinum. 
Bracken crozier samples were collected in the mountainsides of Arcos de Valdevez, Portugal, 
41º 49’ 12’’ N, 8º 24’ 11’’ W, a location where BEH is known to occur. For the method 
implementation phase, the samples used were collected in April 2010 (PA - 2010) and for the 
monitoring stage the samples were collected in April 2014 (PA - 2014). Bracken samples were 
frozen at -20ºC until use. 
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3.3. Reagents and standard solutions 
Pterosin B was obtained in previous work done by Gil da Costa (2011) by isolation from 
Pteridium aquilinum and possessed a purity superior to 99%, determined by nuclear magnetic 
resonance (NMR). HPLC grade reagent methanol (CH3OH) was obtained from VWR International 
and distilled water was used, filtered with Sartolon® polyamide membrane filters (diameter: 
47 mm; pore dimension: 0.45 µm) from Sartorius AG. All other reagents used were of analytic 
or HPLC grade. Prior to use, mobile phase solvents were degassed in an ultrasonic bath for 15 
minutes. 
Stock standard pterosin B solutions were prepared in methanol at 200 µg/mL. Working 
standards in the range of 1 - 80 µg/mL were obtained by dilution with methanol. Stock solutions 
were stored at -18 °C and standard solutions at 5 °C. Ptaquiloside is stable for at least 6 months 
in methanol at -5°C (Oelrichs et al. 1995). 
 
3.4. Instrumentation 
The HPLC used for the quantification was a JASCO modular system with a pumping system 
(PU-2080 Plus Intelligent), a ternary gradient unit (LG-2080-02), a degasser (DG-1580-54 4-
Line), a multiwavelength detector (MD-2015 Plus), a sampler (AS-2057 Plus Intelligent), a LC-
NetII/ADC and a Column Thermostat (CO-2060 Plus Intelligent). The analytical column (Inertsil® 
ODS-3 5 µm; 250 x 4.6 mm I. D.) was preceded by a C18 4x3.0 I. D. Security Guard™ 
(Phenomenex®) guard column. The column was maintained at 25 °C in the column oven. 
Detection was performed at 220 nm, maximum wavelength of pterosin B (Alonso-Amelot et al. 
1992a). All the samples were filtered through nylon filters (diameter: 13 mm; pore dimension: 
0.22 µm) from Nantong FilterBio Membrane Co., Ltd prior to injection. 
Also, for sample processing VirTis benchTop K freeze dryer and Büchi RE 111 Rotavapor with 
a Büchi 461 Water Bath were used. 
 
3.5. Experimental Procedure to Ptaquiloside Isolation from 
Pteridium aquilinum 
The procedure here described was performed according to the one from previous work (Gil 
da Costa 2011). Sample PA - 2010 was processed in this previous work and sample PA - 2014 is 
currently being processed, in accordance with the following procedure. 
Aqueous Extraction: a water-based method, designed for ptaquiloside isolation from 
bracken, was initially adopted, and afterwards modified (Oelrichs et al. 1995). Frozen bracken 
(6 Kg), was blended in distilled water (7.5 L) and stirred at room temperature for 1 hour. 
Aqueous Extract Adsorption-Desorption: the aqueous extract (7 L) was filtered through a 
series of strainers and adsorbed onto a 1 L resin column, Amberlite XAD-2 (Supelco), at an 
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average flow of 10 mL/min. The adsorbed compounds were eluted with methanol (1.5 L), 
through a series of adsorption-desorption cycles in order to maximize the removal of all 
relevant compounds. A final desorption with water was performed. 
Extraction with Butanol: the methanol extract was concentrated at low temperature 
(below 50ºC) under reduced pressure, dissolved in distilled water (400 mL) and extracted with 
n-butanol (5 x 500 mL). 
Butanolic Extract Fractioning with Silica Gel Column Chromatography: the i-butanol 
extract was concentrated at low temperature (below 50ºC) under reduced pressure, and 
chromatographed on silica gel 60 (0.2-0.5 mm, Merck), collecting 500 mL fractions with CHCl3 
(5 L), EtOAc (6 L), EtOAc – CH3OH in different percentages (%, v/v, 3 L): 92:8; 75:25; 50:50; 
25:75 and CH3OH (3 L). All fractions were controlled for the presence of ptaquiloside by 
1H and 
13C NMR, with a Brucker Avance III 400 spectrometer. Samples dissolved with adequate 
deuterated solvents. 
Purification on ODS-silica gel Column Chromatography: the fractions found to contain 
ptaquiloside were chromatographed twice on octadecyl-sylane (ODS) silica gel (C18 100-40/75, 
Fuji-Silysia) with CH3OH -H2O (20:80 and 40:60, %, v/v) and CH3OH.  
 
3.6. Development and Validation of Ptaquiloside Quantification 
Method 
3.6.1. Chromatographic Conditions Studies to Pterosin B Quantification 
In order to assay time retention variation of pterosin B with different mobile phase 
compositions, different compositions were used, from CH3OH:H2O (60:40 %, v/v) until 
CH3OH:H2O (80:20 %, v/v), using the same sample of known concentration (25 µg/mL). Analysis 
time was 30 minutes to all the experiments. A flow rate of 1 mL/min was used and all samples 
were measured in quadruplicate. 
Determination of linearity was made by calculation of a regression line from the peak area 
vs concentration plot for six standard solutions (1, 5, 10, 25 and 80 µg/mL). 
The limit of detection (LOD) was expressed as (ICH 2005): 
LOD = 3.3 sb/a          (1) 
where sb is the error associated with the intercept and a is the slope of the calibration curve. 
The LOD was studied using samples from the calibration curve. 
The limit of quantification (LOQ) was expressed as (ICH 2005): 
LOQ = 10 sb/a          (2) 
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where sb is the error associated with the intercept and a is the slope of the calibration curve. 
The LOQ was studied using samples from the calibration curve, according to ICH guidelines (ICH 
2005). 
The specificity of the analytical method was ascertained with samples of pterosin B 
submitted to conditions of thermal, acidic and alkaline stress. To assess thermal degradation, 
a known concentration (25 µg/mL) of pterosin B was placed in an oven at 80ºC for 24 h. Then, 
the samples were filtered and subjected to HPLC analysis. For evaluation of pterosin B 
degradation in acidic and alkaline conditions, 100 µL of a known concentration (25 µg/mL) of 
pterosin B was mixed with 100 µL of 2.5 M H2SO4 and with 100 µL of 1 M NaOH. Following 36 h 
at room temperature, the samples were filtered and subjected to HPLC analysis. Control 
samples (with CH3OH) were also prepared and assayed. 
With the objective of confirming the ability of the method to detect pterosin B in samples, 
a standard of known concentration (200 µg/mL) was added to a sample. This solution was 
filtered and injected. 
In order to verify the method specificity when using complex samples rather than just 
standards, a peak enrichments of extracts with known amounts of standards was performed. 
0.3 mL of a sample were added to 0.3 mL of a standard (200 µg/mL). The analysis was 
performed in the conditions stated above. 
Accuracy was evaluated using a minimum of nine determinations over a minimum of three 
concentrations levels (5, 25 and 80 µg/mL) and by calculating the relative standard deviation 
(RSD). 
Repeatability (intra-assay precision) of the chromatographic method was investigated by 
the analysis on the same day of five pterosin B standard solution (three replicates each). 
Intermediate precision was studied by the analysis of the same standard solutions on three 
different days, and described as SD and RSD. 
The total analytical method repeatability was determined by executing six replicate 
samples of the same sample containing pterosin B. 
For calculations and statistic determination Microsoft® Excel was used. 
 
Quantification of pterosin B in samples from previous ptaquiloside isolation 
procedure: in order to validate this method for pterosin B quantification in complex samples, 
a sample known to possess this compound, previously obtained by column chromatography (PA 
2010), was analysed. 
The mobile phase was methanol-water (70:30 %, v/v) for pterosin B. The flow rate was 1 
mL/min. A 20-μL sample injection volume was used for all analysis. Detection was performed 
at 220 nm, maximum wavelength of pterosin B. Concentration calculations were based on area 
measurements relative to standards of concentrations in the range of 1-80 µg/mL. JASCO 
ChromPass Chromatography Data System software managed chromatographic data. 
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3.6.2. Studies on Ptaquiloside Conversion to Pterosin B 
In order to validate this method for ptaquiloside quantification, samples controlled for the 
presence of ptaquiloside by 13C NMR, from previous work (Gil da Costa 2011), obtained using 
column chromatography, were analysed. 
 
Preparation of sample solutions for Pterosin B determination before conversion: 
samples were collected from each step of the isolation procedure. For the samples in methanol, 
solvent was evaporated under a current of nitrogen, the sample was weighted and the residue 
re-dissolved in HPLC-grade methanol. Aqueous samples were freeze dried, weighted and re-
dissolved in water. In order to assess the initial content in pterosin B, 100 µL of sample were 
diluted in 1050 µL of CH3OH. Samples were filtered and injected. 
 
Ptaquiloside to Pterosin B Conversion: 100 µL of the sample were diluted in 900 µL of 
water and treated with 75 µL of 1 M NaOH and allowed to react for 1 h at 40 °C. Afterwards, 
75 µL of 2.5 M H2SO4 were added. The concentration was calculated on the basis of 100% 
conversion of ptaquiloside to pterosin B. 
 
Chromatographic Analysis: the mobile phase was methanol-water (70:30 %, v/v) for 
pterosin B. The flow rate was 1 mL/min. A 20 μL sample injection volume was used for all 
analysis. The mobile phase was selected to result in a retention time of approximately 8-9 min 
for pterosin B. Detection was performed at 220 nm. Concentration calculations were based on 
area measurements relative to standards of concentrations in the range of 1-80 µg/mL. JASCO 
ChromPass Chromatography Data System software managed chromatographic data. In order to 
validate the calibration curve obtained, a standard (25 µg/mL) was injected daily. 
 
Ptaquiloside Determination: with the initial concentration of pterosin B and the 
concentration after conversion, it is possible to calculate ptaquiloside concentration in the 
sample. Knowing the initial weight of the analysed samples the concentration of ptaquiloside 
is expressed in % (w/w). For expressing the concentration of ptaquiloside in terms of dry weight 
basis, moisture content of bracken fern was estimated keeping a known quantity of fern in an 
oven at 120ºC until constant weight. The result was expressed as mg/g. 
 
3.7. Monitoring of Ptaquiloside Isolation Method 
After validation of the quantification method, the same methodology described above was 
applied to the samples collected in April 2014 (PA - 2014), with the objective of optimizing the 
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number of adsorption-desorption cycles in the isolation process. Samples analysed are 
described in Table 5. 
As stated in Table 6 the number of adsorption-desorption cycles varied with the extraction 
experiment. 
 
Table 5 - Samples analysed to monitor the extraction process, from PA – 2014 bracken samples. 
Extraction Sample Description Weight (mg) 
A 
A1 Aqueous Extract 26 
A2 1st cycle of methanol adsorption-desorption 15 
A3 2nd cycle of methanol adsorption-desorption 2 
A4 3rd cycle of methanol adsorption-desorption 4 
A5 4th cycle of methanol adsorption-desorption 2 
A6 5th cycle of methanol adsorption-desorption 7 
A7 Final Aqueous Extract 10 
B 
B1 Aqueous Extract 20 
B2 1st cycle of methanol adsorption-desorption 18 
B3 2nd cycle of methanol adsorption-desorption 20 
B4 3rd cycle of methanol adsorption-desorption 19 
B5 Final Aqueous Extract 19 
C 
C1 Aqueous Extract 22 
C2 1st cycle of methanol adsorption-desorption 6 
C3 2nd cycle of methanol adsorption-desorption 2 
C4 3rd cycle of methanol adsorption-desorption 1 
C5 Final Aqueous Extract 17 
 
Table 6 - Sample collection and variation of adsorption-desorption cycles. 
 
Date of 
Sampling 
Extractions 
Weight 
(kg) 
Adsorption-desorption 
cycles 
PA - 2010 April 2010 1 11 7 
PA - 2014 April 2014 
1 6 5 
2 6 3 
3 6 3 
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4. Results and Discussion 
4.1. Development and Validation of Ptaquiloside Quantification 
Method 
4.1.1. Chromatographic Conditions Studies to Pterosin B Quantification 
Based on the literature, several proportions of mobile phase CH3OH: H2O were studied in 
order to obtain a satisfactory retention time, varying from CH3OH: H2O (60:40, v/v) to 
CH3OH:H2O (80:20, v/v). In this study, the injected standard had a concentration of 25 µg/mL, 
the analysis time was 30 minutes and all the injections were performed in duplicate. 
With mobile phase composition CH3OH:H2O (60:40, v/v) a peak around 21 minutes was 
obtained (Figure 7a). For the quantification of numerous samples this is a long time of analysis. 
Since with increasing methanol the mobile phase polarity decreases and with decreasing 
polarity, pterosin B elutes faster (since a reverse phase column was used), a less polar mobile 
phase was tested.  
For CH3OH:H2O (70:30, v/v), as it would be expected, a decreasing of the retention time 
occurs and pterosin B is eluted at approximately 10 minutes (Figure 7b). This is a more adequate 
time of analysis for compound quantification and with this mobile phase composition there is 
no other interference peaks in the surroundings. Also, the peak signal suffers an intensification 
and a narrowing (increased resolution), as anticipated.  
This is a mobile phase composition that fulfils all the criteria for compound quantification, 
with an acceptable retention time and with a good separation factor, that also allows compound 
separation. 
As can be observed in Figure 7c, with an increase in methanol (CH3OH:H2O (80:20, v/v )) a 
further decrease in retention time occurs (around 7 minutes). Although it is a shorter analysis 
time, the pterosin B peak is too close to the mobile phase peaks, which implies a decrease in 
the separation factor. This parameter measures the analysis selectivity for two adjacent peaks. 
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Figure 7 - Mobile phase analysis chromatograms. a: CH3OH:H2O (60:40, v/v); b: CH3OH:H2O (70:30, v/v); 
c: CH3OH:H2O (80:20, v/v). 
 
In Table 7 the variation of retention time with the variation of the mobile phase composition 
can be observed. 
Table 7 – Pterosin B retention time with mobile phase variation. 
Mobile Phase 
(CH3OH:H2O, v/v) 
Retention time (minutes) 
60:40 21 
70:30 11 
80:20 7 
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The mobile phase composition that provides the lower retention time is CH3OH:H2O (80:20, 
v/v), however the separation factor obtained in this conditions is lower than the one of 
CH3OH:H2O (70:30, v/v). 
Best conditions were achieved with CH3OH:H2O (70:30, v/v). A flow rate of 1 mL/min gave 
an optimal signal to noise ratio and a reasonable separation time. The maximum absorption of 
pterosin B in the experimental conditions was found at 220 nm (Agnew & Lauren 1991; Ayala-
Luis et al. 2006; Somvanshi & Lauren 2006; Jensen et al. 2008; Fletcher et al. 2011), which was 
the selected wavelength for the analysis. These conditions are adequate to isolate and quantify 
the compound and they provide a suitable time of analysis (around 15 minutes). 
 
The method has an adequate linearity over the range of 1-80 µg/mL. The regression 
equation was: y=0.7009(±0.0195)x-0.3841(±0.7804). The square of correlation coefficient (R2) 
was 0.9969 and the correlation coefficient (R) was 0.9985. The calibration curve can be found 
in the Appendix B.1. The calibration curve obtained also satisfies all the criteria for validation 
(the slope relative standard deviation lower than 5% and b-sb < 0 < b+sb, in order to guarantee 
that for null concentration a null response is obtained) (Skoog et al. 1992). 
The limit of quantification was determined to be 11.13 µg/mL and the limit of detection 
was 3.67 µg/mL. Other authors were able to achieve smaller LOD, such as 0.5 µg/mL (Alonso-
Amelot et al. 1998), 0.0003 µg/mL (Bonadies et al. 2011) and 0.1 µg/mL (Rasmussen et al. 
2005). The limit of detection is the concentration corresponding to a signal to noise ratio of 
3:1. Therefore, there are only two things that can be done in order to improve the LOD of a 
HPLC method: increase the signal or decrease the noise. The signal can be increased by 
operating at the optimal UV wavelength of the analyte. As mentioned before pterosin B has 
maximum wavelengths at 214, 220 and 260 nm. In this work analysis at 260 nm was tested and 
at this wavelength the signal intensity was decreased when compared with 220 nm. For future 
work a calibration curve at 214 nm should be tested to verify if the signal intensity can be 
increased. To diminish the noise of the analysis other mobile phase solvents should be tested, 
and comparing with the literature other alternative for methanol (cutoff 205 nm) is acetonitrile 
(cutoff 190 nm) (Pavia et al. 2001). 
The specificity of the method was evaluated by comparing the chromatograms of standard 
pterosin B with the chromatograms resulting from the stress conditions (temperature (80ºC), 1 
M H2SO4 and 1 M NaOH). 
When pterosin B standard (25 µg/mL) was submitted to thermal, acidic and alkaline stress 
conditions the chromatograms remain similar to the chromatogram of the standard solution. 
For acid and alkaline conditions a peak with the retention time of approximately 2.5 minutes 
appeared due to the addition of acid and base. Additionally, the absence of any peak in the 
region of pterosin B elution time indicates the specificity of the developed method, regarding 
the conversion interferents. In general, the data acquired gives evidence that the method can 
be considered as specific since no interfering peaks were observed. 
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The accuracy of this method was also tested and detailed results for the three 
concentration levels tested are presented in the Appendix B.2. The mean recovery was found 
to be 104.93±8.49 %, revealing a solid agreement between theoretical and experimental values. 
Repeatability (intra-day precision) and intermediate precision (inter-day precision) of the 
developed method can be consulted of the Appendix B.3. As can be observed in the Appendix 
B.3, all of the relative standard variations were inferior to 10%, showing that the method has 
intra-day and inter-day precision. 
 
The analytical method is effective, fast and meets all criteria for method validation and 
can be applied to the quantification of pterosin B. 
Simple sample preparation procedure and retention time lower than 10 minutes allow the 
quantification of several samples in a short period of time. The suggested method is free from 
interferences of other compounds used in the conversion method and no degradation of the 
compound was found. 
 
The quantification of pterosin B in samples from previous ptaquiloside isolation 
procedure was performed in order to assess this method validity analysing, one sample derived 
from the purification with ODS step of the isolation process (PA – 2010). 
The chromatogram of the sample with addition of the standard was compared with the one 
of sample without addition of standard. In Figure 8, a comparison between the two 
chromatograms is made (black represents the sample and red represents the sample with 
standard addition). At 7 minutes there is an increase in the peak of pterosin B, which confirms 
the presence of this compound in the analysed sample. Due to the standard addition, a decrease 
in the remaining peaks can be observed, once this compounds were diluted while pterosin B 
was concentrated. 
 
 
Figure 8 - Comparison of the sample with and without addition of a standard. Black: sample without 
standard; red: sample with addition of standard. 
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4.1.2. Studies on Ptaquiloside conversion into Pterosin B 
To assess the application of this quantification method, samples of the isolation 
performed by Gil da Costa (2011) were used for its implementation. Nine samples, representing 
different stages of the isolation process, were chosen from this previous work (Figure 9). These 
samples correspond to: aqueous extract (sample A), methanolic eluate from the adsorption-
desorption step of the extract from the Amberlite resin (sample B), butanolic extract obtained 
after Bu-H2O partition of dried methanolic extract (sample C), two EtOAc/CH3OH fractions from 
preparative chromatography (stationary phase –ODS silica gel) (samples D and E) and four 
fractions derived from sequential purifications in preparative chromatography (stationary phase 
– ODS silica gel) (samples F to I). 
 
Figure 9- Ptaquiloside isolation method from bracken. Adapted from (Gil da Costa 2011) 
 
All the fractions obtained during the chromatography steps were controlled by 13C NMR, 
in order to detect ptaquiloside and/or pterosin B. This is possible due to the existence of two 
signals around δ 6 and 11 ppm, very unusual and characteristic of the ptaquiloside chemical 
family, corresponding to the carbons C-12 and C-13, respectively. These signals do not appear 
in the pterosin B spectrum and the corresponding signals appear at δ 32 and 62 ppm. The 13C 
NMR spectra (attached proton test (APT) technique) of ptaquiloside (a), pterosin B (b) and of 
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sample G (c) are presented in Figure 10. NMR data related to ptaquiloside and pterosin B is 
presented in the Appendix C. 
As can be observed sample G contains the characteristics signals of ptaquiloside around 
δ 6 and 11 ppm, confirming the presence of this compound in the sample while in pterosin B 
those carbons appear at δ 32 and 62 ppm, respectively. Additionally the presence of a signal 
between δ 200-220 ppm typical of the ketone carbonyl carbon is detected. This type of carbon 
can be found not only in ptaquiloside but also in pterosin B and corresponds to carbon C-1 and 
this signal corresponds to the carbon 1 both in ptaquiloside and pterosin B. However, in pterosin 
B this signal occurs at inferior values (around δ 210 ppm) of ptaquiloside (around δ 220 ppm), 
due to the conjugation of the carbonyl group with the aromatic ring present in pterosin B. 
These signals allow an assessment of ptaquiloside degradation in samples during 
storage/processing. 
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Figure 10 - 13C NMR spectra (apt) for pterosin B (a), ptaquiloside (b) and sample G (c). 
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Ptaquiloside Determination 
In order to assess this method’s validity for ptaquiloside quantification, the ptaquiloside 
content in samples from previous work (Gil da Costa 2011) was determined (PA - 2010). After 
all samples were analysed, pterosin B content before and after conversion was calculated 
through the calibration curve previously obtained. Ptaquiloside concentration was obtained 
subtracting the initial pterosin B content to the conversion one. This calculations assumed a 
100% conversion of ptaquiloside to pterosin B. 
The results obtained are summarized in Table 8. 
 
Table 8 - Samples analysed from PA - 2010 extraction process. 
Sample PtBinitial (µg/mL) 
Pta 
(µg/mL) 
w (mg) % w/w (mg/mg sample) 
PtB Pta PtB Pta 
A 42.97±0.90 0.00 0.09 0.00 0.86 0.00 
B 8.80±1.73 0.00 0.02 0.00 0.18 0.00 
C 784.22±15.30 267.73 3.14 1.07 5.60 1.91 
D 318.27±66.21 559.91 0.32 0.56 0.38 0.67 
E 272.74±16.57 130.44 0.27 0.13 0.29 0.14 
F 249.36±22.51 873.70 0.25 0.87 0.17 0.60 
G 304.14±11.87 2269.77 0.60 4.54 3.03 22.93 
H 661.60±34.34 2794.60 0.66 2.79 0.94 3.96 
I 4739.68±132.96 630.05 4.74 0.63 6.84 0.91 
 
With this method it is possible to monitor the extraction process and to understand which 
steps are relevant to the procedures and where the compound is might being lost. 
Analysing the results obtained for this extraction process monitoring, a null conversion of 
ptaquiloside to pterosin B can be observed in sample A. This sample corresponds to the aqueous 
extract and due to its nature it can be stated that any ptaquiloside or ptaquiloside-alike 
compound present in the sample was slowly transformed into pterosin B during storage or 
ptaquiloside was present in the sample in a concentration below the limit of detection. 
In sample B, the ptaquiloside content in this sample is residual or non-existent. This sample 
corresponds to the aqueous extract after passage through the amberlite resin, in which all of 
ptaquiloside should have been adsorbed, which is confirmed by the monitoring method. 
Nevertheless, once this sample is also of aqueous nature the absence of ptaquiloside content 
can also be due to degradation during storage. As stated in the Introduction section of this 
work, ptaquiloside is only stable for six months at low temperatures (Yamada et al. 2007). 
The isolation process described in Figure 9 was performed aiming for ptaquiloside 
concentration and eliminating the other bracken components present in the aqueous extract. 
When analysing the remaining samples, an increase of the ptaquiloside content in sample G can 
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be observed, which is in accordance with the NMR conclusion that this sample possessed 
ptaquiloside. Of all the analysed samples this was the one with superior ptaquiloside content. 
With this ptaquiloside quantification method, it is possible to promptly monitor ptaquiloside 
isolation, unlike with NMR, which is a slower technique and not so adequate for rapid 
quantification. NMR requires a more expensive equipment as well as the use of deuterated 
solvents which results in a costly analysis method. The technique applied for ptaquiloside 
quantification (13C) is time-consuming and has a lower sensitivity due to the decreased 
percentage of carbon 13 isotope (1.1%) present in the molecules (Silvestein & Webster 1998). 
NMR has the advantage of being a non-destructive method. 
In the other hand, HPLC is a quicker method for compound quantification (only requires a 
quick preparation of the initial sample and the conversion of the same, without elimination of 
solvents) and also allows the identification of other compounds in samples as well as the 
analysis of several samples in a short period of time, which enables a good monitoring of the 
isolation process. In this case, the results obtained from both HPLC and NMR are in accordance. 
 
4.2. Monitoring of the Ptaquiloside Isolation Method 
A new extraction process was initiated in April of 2014 and samples (P. A. - 2014) were 
taken from the resin adsorption and methanol elution steps (Figure 11), as described in Table 
5. This extraction process was divided into three phases (A, B and C) due to the amount of 
bracken samples collected (18 kg) and corresponds to the clean-up and concentration of the 
aqueous extract. In this process the aqueous extract is adsorbed to the resin and then the 
compound of interest is desorbed with methanol (CH3OH elution). 
 
 
Figure 11 - Sampling for the monitoring of ptaquiloside extraction. 
 
For extraction A an unknown volume of the aqueous extract was freeze dried, whereas for 
extractions B and C the volume lyophilized was 2 mL. Afterwards the aqueous extracts were 
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weighted and re-dissolved in distilled water. An initial analysis of the aqueous extract was 
performed in order to assess the initial content in pterosin B (Figure 12a). 
 
 
Figure 12 - Chromatogram obtained for initial analysis of Sample A1. a: at 220 nm; b: at 220 nm (black) 
and 260 nm (red); c: with (blue) and without (red) addition of a PtB standard. 
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As can be observed, there are 3 peaks between 6 and 8 minutes. Although the pterosin B 
peak usually occurs at approximately 8 minutes, there was some doubt about the retention 
time of this compound. With the objective of ascertaining which peak corresponded to the 
compound, an analysis at 260 nm (other of pterosin B maximum wavelength), due to the 
aromatic nature of pterosin B, was also performed (Figure 12b). 
At 260 nm, a peak can be observed at around 6 minutes of retention time. This supported 
the hypothesis that the retention time of pterosin B had changed. Nevertheless, another 
confirmation analysis was performed, an injection of Sample A1 with addition of a standard of 
pterosin B (Figure 12c). 
This analysis confirm the hypothesis of a variation in the pterosin B retention time. This 
change can be due to the usage of the chromatographic column, alterations in sample 
temperature or due to the matrix effect of analysing real samples. At this point the pterosin B 
retention time was considered to be around 5-6 minutes. 
For the quantification of the converted sample a confirmation of the peak was also 
performed, resorting to the 260 nm analysis and to the standard addition method (Figure 13). 
 
 
Figure 13 - Chromatogram of Sample A1 converted (black) and with standard addition (red) at 220 nm. 
 
In this case, the pterosin B peak occurs around 5.5 minutes of retention time, in accordance 
with what was stated above. 
In Table 9, the results obtained for the analysed samples of extraction A are summarized. 
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Table 9 – Ptaquiloside and Pterosin B content for analysed samples of extraction A. 
Sample 
PtBinitial 
(µg/mL) 
Pta 
(µg/mL) 
w (mg) % w/w (mg/mg sample) 
PtB Pta PtB Pta 
A1 10.08±0.30 2.90 0.30 0.13 1.16 0.49 
A2 28.58±2.16 28.59 0.11 0.11 0.76 0.76 
A3 977.97±36.38 0.00 3.91 0.00 55.88 0.00 
A4 26.57±6.06 0.00 0.11 0.00 5.31 0.00 
A5 22.34±3.91 0.00 0.09 0.00 2.23 0.00 
A6 34.41±7.51 0.00 0.14 0.00 6.88 0.00 
A7 11.88±0.00 0.00 0.05 0.00 0.68 0.00 
A8 < LOQ < LOQ < LOQ < LOQ < LOQ < LOQ 
 
In Sample A1 is important to highlight that the value of initial pterosin B is inferior to the 
limit of quantification (11.13 µg/mL), nevertheless this value was considered for the 
ptaquiloside determination due to its proximity to the LOQ. 
By evaluating the results described in the table above, it can be observed that, after sample 
A3, the content in ptaquiloside is null. Accordingly, it can be concluded that all the interest 
compound was removed from the resin with only one passage of methanol, and, therefore, the 
following methanol cleanings can be removed from the isolation method. 
In sample A8 the value obtained for pterosin B content was inferior to the limit of detection 
(LOD: 3.67 µg/mL). In this case, a null concentration of ptaquiloside can be considered, 
according to the results for the previous samples, which had no ptaquiloside content. 
Nevertheless, in Sample A3, an increase on the initial content in pterosin B can be observed. 
This increase in pterosin B can be due to ptaquiloside conversion during the adsorption-
desorption, which means that in this step a great amount of ptaquiloside was lost. This proves 
the importance of celerity in the isolation process in order to reduce the loss of ptaquiloside 
due to decomposition. 
In this extraction process, the volume of the samples collected was unknown, which limited 
the calculation of the ptaquiloside content in bracken samples. This way, in future sampling all 
the volumes were registered in order to allow ptaquiloside quantification. 
 
In Table 10 results obtained for the analysed samples of extraction B are summarized. 
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Table 10 - Ptaquiloside and Pterosin B content for analysed samples of extraction B. 
Sample 
PtBinitial 
(µg/mL) 
Pta 
(µg/mL) 
w (mg) % w/w (mg/mg sample) 
PtB Pta PtB Pta 
B1 130.55±7.57 0.00 0.26 0.00 1.31 0.00 
B2 23.61±0.61 15.71 0.05 0.03 0.026 0.17 
B3 16.68±1.65 6.52 0.03 0.01 0.17 0.07 
B4 15.08±3.40 3.75 0.03 0.01 0.16 0.04 
B5 33.13±1.74 0.00 0.07 0.00 0.35 0.00 
 
In extraction B, and taking into account the results obtained from extraction A, only three 
adsorption-desorption cycles were performed and the waiting time between cycles was 
minimized. Sample B1 displays no ptaquiloside content, however since this is the aqueous 
extract this result cannot be truthful. The freeze drying process that was performed during 
sample processing before quantification may be the cause for this result. During the 
lyophilisation of sample B1 a technical problem occurred with the equipment which led to the 
sample being in aqueous solution at room temperature some time, thus, resulting in 
ptaquiloside decomposition previous to the conversion step. 
Nevertheless, a 0.17 % (w/w) ptaquiloside content can be observed in the results for Sample 
B2, which confirms that the results for sample B1 are not accurate. From this adsorption-
desorption cycle a decrease in the ptaquiloside content is detected until reaching a 0.04 % 
(w/w) ptaquiloside content. 
Sample B5 corresponds to a final aqueous extract and the outcome for ptaquiloside content 
(0.00 % (w/w)) corroborates the hypothesis that all ptaquiloside was removed from the aqueous 
extract with three adsorption-desorption cycles. 
Concerning extraction C ptaquioside determination, the results are present in Table 11. 
 
Table 11 - Ptaquiloside and Pterosin B content for analysed samples of extraction C. 
Sample PtBinitial (µg/mL) Pta (µg/mL) 
w (mg) % w/w (mg/mg sample) 
PtB Pta PtB Pta 
C1 64.11±2.46 25.95 0.13 0.03 0.58 0.24 
C2 19.92±10.30 35.60 0.04 0.07 0.66 1.19 
C3 121.03±7.37 0.00 0.24 0.00 12.10 0.00 
C4 21.52±10.45 0.00 0.04 0.00 4.30 0.00 
C5 27.80±3.55 0.00 0.06 0.00 0.33 0.00 
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By analysing the results from extraction C, a decrease in ptaquiloside content can be 
perceived through the adsorption-desorption cycles. In this extraction, all the ptaquiloside 
content was removed with the first resin adsorption-methanol elution cycle and after that 
ptaquiloside was not possible to detect. Nonetheless, in sample C3 and increase in pterosin B 
content can be noticed, which can be related with loss of ptaquiloside during the extraction 
process or during sample storage. 
One of the major concerns with this quantification method is the loss of ptaquiloside due 
to pour handling of the samples. It is vital to highlight the importance of celerity not only in 
the isolation process, but also in the quantification method, in order to avoid inadequate 
ptaquiloside quantifications. 
 
Furthermore, the ptaquiloside content in bracken may be estimated through the 
ptaquiloside concentration in the initial aqueous extract. Assuming a 100% conversion of 
ptaquiloside to pterosin B, the total content of ptaquiloside can be calculated in terms of dry 
weight basis. Once Sample C1 represents the aqueous extract and considering a full extraction 
of ptaquiloside, it can be extrapolated that the ptaquiloside content in bracken fern is 0.30 
mg/g in dry weight basis. This value is similar to the ones found in literature, as the maximum 
concentration was 4.450 mg/g measured by (Rasmussen, Kroghsbo, et al. 2003) when analysing 
samples from the whole plant. 
This is the first estimate of ptaquiloside content in Pteridium aquilinum made in continental 
Portugal and regarding the reported values for bracken croziers in dry weight basis, this value 
can only be compared with studies of Alonso-Amelot (Alonso-Amelot et al. 1992a; Alonso-
Amelot et al. 1992b),. In 1992, this group reported a ptaquiloside concentration in croziers of 
1.6 mg/g and 1.9 mg/g. This value is a superior to the one obtained in this work, which, as 
stated before, is correlated to the plant growth region, as well as the climacteric conditions 
during growing season. 
 
 
5. Conclusions 
37 
 
5. Conclusions 
Bracken fern is an ancient plant that grows abundantly worldwide and is toxic to many 
animals’ species. 
P. aquilinum possesses a unique ability to spread (through the rhizome system and/or spores 
proliferation), which combined to its aptitude to resist insect attacks, microorganisms and 
unfavourable weather, contributed to the efforts that has been dedicated to its control and to 
understanding its harmfulness.  
About 100 metabolites have been isolated from bracken. Of these, ptaquiloside, an unstable 
norsesquiterpene glycoside of the illudane type, is the one responsible for most of the fern’s 
carcinogenicity. 
Ptaquiloside is soluble in water and it has been reported that it is clastogenic, mutagenic 
and teratogenic. Its elevated toxicity is associated with the electrophilic properties of the 
unstable three carbon ring (cyclopropyl group), that alkylates a wide variety of nucleophiles 
(biomolecules such as nucleotides). 
In bracken, the concentration of some sesquiterpenoids have been known to vary 
significantly along the growing season and is dependent of the plant compartment, even so, 
ptaquiloside concentrations up to 37 mg/g dry weight in mature fronds have been reported. It 
is known that ptaquiloside appears in higher concentration in the crozier than in the mature 
frond. In the present work, ptaquiloside has been quantified in bracken croziers, for the first 
time in samples from continental Portugal, representing 0.30 mg/g (dry weight). 
Nowadays, high pressure liquid chromatography is the most used method for ptaquiloside 
quantification. In this work, an HPLC quantification was applied, recurring to a conversion of 
ptaquiloside to pterosin B, through a base-heat-acid treatment, followed by analysis at 220 nm 
and using as mobile phase methanol:water 70:30 (v/v). 
After monitoring the first extraction it was possible to conclude that there was no need for 
five adsorption-desorption cycles, and for the next extraction the number of cycles was reduced 
to three, while the waiting time between cycles was minimized. 
Using this ptaquiloside quantification method, it is possible to promptly monitor 
ptaquiloside isolation, unlike with NMR, which is a slower technique and not so adequate for 
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rapid quantification. The HPLC quantification only requires a quick preparation of the initial 
sample and the conversion of the same. 
The application of this method throughout all the isolation process is of extreme importance 
in order to ascertain how this process can be accelerated, since ptaquiloside losses due the 
process’s duration is one of the major causes of its low yield. 
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Appendix 
A. Survey from the literature 
Table 12 - Review of the Ptaquiloside/Pterosin B quantification methods developed so far. 
Reference Sample Cleaning Conversion of Pta to PtB 
Pta/PtB Quantification 
Equipment Column Mobile Phase 
Flow-
rate 
(mL/min) 
Retention 
Time 
Sample 
Injected 
Conditions 
Saito et 
al. 1991 
------ 
Thin Layer 
Chromatography 
Silica Gel TLC plate (20x10 
cm) 
------ ------ ------ ------ ------ 
TLC-densitometry 
at 250 nm 
Agnew & 
Lauren 
1991 
20 mL of filtrate were 
added to a glass column 
(25 cm x 12 mm) dry 
packed with polyamide 
6S resin (2.5 g) 
1 mL of eluate + 75 µL/mL 
of NaOH 1 M HPLC system Spectra-
Physics 740B 
(binary pumping system 
with a Rheodyne 7120 
manual injector or a 
Micrometrics 725 
autosampler; a 50 µL 
sample loop; a 
Micrometrics 731 column 
oven; a Shimadzu SPD-2A 
UV Detector; a Spectra-
Physics SP4170 integrator) 
Zorbax ODS 5 µm 
or 
Chrompak 
CPSpher C8 (25 
cm x 4.6 mm I. 
D.) with a MPLC 
RP-8 guard 
column 
H2O: CH3OH (60:40, 
v/v) for Pta and H2O: 
CH3OH (40:60, v/v) for 
PtB 
1 
10-12 min 
for Pta 
and PtB 
50 µL 
35 ºC 
220 nm 
↓ 
1 h at 40 °C 
↓ 
Add 75 µL/mL of HCl 5 M 
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Reference Sample Cleaning Conversion of Pta to PtB 
Pta/PtB Quantification 
Equipment Column Mobile Phase 
Flow-
rate 
(mL/min) 
Retention 
Time 
Sample 
Injected 
Conditions 
Alonso-
Amelot et 
al. 1992 
--- --- 
HPLC system LDC Milton 
Roy 
(Constametric II pump; 
Rheodyne 20 µL loop 
injector; Waters 490E 
multichannel UV-VIS 
detector) 
Radial 0.5 x 10 
cm C-18 
H2O: CH3OH (35:65, 
v/v)in  isocratic mode 
1 
10 min 
for Ptb 
20 µL 
Room temperature 
260 nm for PtB 
Dawra et 
al. 2002 
--- --- 
Waters HPLC system 
(510 and 515 pump; 
Rheodyne injector; 490E 
multichannel detector) 
C-18 Reverse-
phase 
(4.6 x 250 mm) 
C2H3N:H2O gradient 
(20:80, v/v for first 20 
min followed by 
increase to 100% 
acetonitrile in the next 
20 min) 
1 --- --- --- 
Rasmussen 
2003 
Agnew and Lauren 
method 
1 mL of eluate + 75 µL/mL 
of 1 M NaOH 
HPLC system Merck Hitachi 
(T-6300 column 
thermostat; L4200 UV-Vis 
detector; 655A-40 Auto 
sampler; D-6000A 
Interface; L-6200 
Intelligent pump) 
Merck 
LiChroCART® 
(LiChrospher® 
100 RP-8, 5 µm) 
125 x 4 mm, 4x4 
mm I.D. Merck 
LiChroCART® 
(LiChrospher® 
100 RP-18e, 5 
µm) safe guard 
column 
H2O: C2H3N gradient --- --- --- 
35 ºC 
220 nm Pta 
214 nm PtB B 
↓ 
1 h at 45 °C 
↓ 
Add 75 µL/mL of 5 M HCl 
Bonadies 
et al. 
2004 
----- 
400-500 mL of aqueous 
solution + 75 µL/mL of 1 M 
NaOH 
GC/MS 
HP5890 gas chromatograph 
HP5 MS column 
(30 m) 
----- ----- ----- ----- ----- 
↓ 
1 h at 45 °C 
↓ 
Add 75 µL/mL of HCl 5 M 
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Reference Sample Cleaning Conversion of Pta to PtB 
Pta/PtB Quantification 
Equipment Column Mobile Phase 
Flow-
rate 
(mL/min) 
Retention 
Time 
Sample 
Injected 
Conditions 
Rasmussen 
et al. 
2005 
Polyamide 6 resin 
(Fluka): 4 mL aqueous 
extract was passed 
through 0.50 g resin 
(dry packed) on a 1.0 x 
10 cm I.D. glass Econo-
Column® (BIO-RAD) 
fitted with a 28 µm 
polymer filter 
Agnew and Lauren Method 
Merck HPLC system 
(L-4200 UV-VIS detector; 
655A-40 auto-sampler, D-
6000A Interface and L-
6200 Intelligent pump) 
Merck 
LiChroCART® 
(125 x 4 mm) 
packed with 
LiChrospher® 100 
RP-8, 4 µm 
Pterosin B: 
double deionised H2O: 
C2H3N (83:17, v/v) 
Ptaquiloside: 
MillQ-H2O: C2H3N (92:8, 
v/v) 
1 --- 20 µL 
35 ºC 
220 for Pta 
214 nm for PtB 
Ayala-Luis 
et al. 
2006 
--- --- 
Merck Hitashi HPLC system 
(T-6300 column 
thermostat; L-4000 UV-VIS 
detector; 655A-40 auto-
sampler; D-6000A 
Interface, L-6200 
intelligent pump) 
Merck 
LiChroCART® 
(125 x 4 mm) 
packed with 
LiChrospher® 100 
RP-8, 4 µm 
Merck 
LiChroCART 
guard column 
(Lichrospher 100 
RP-18e, 4 x 4 
mm) 
Isocratic mode: C2H3N: 
H2O (18:82, v/v) 
Gradient mode: started 
with the isocratic mode 
and after 10 min, a 
gradient was applied 
until reaching C2H3N: 
H2O (55:45, v/v) 
1 
Pta: 8 
min 
PtB: 12 
min 
--- 
35 ºC 
220 nm 
Somvanshi 
& Lauren 
2006 
0.75 mL of supernatant 
was added to 0.250 g of 
methanol-washed 
polyamide powder 
1 mL of supernant 
Reversed-phase HPLC 
(Waters HPLC system) 
510 and 515 binary 
pumping system, rheodyne 
injector, 490 E 
multichannel detector 
C18 reverse phase 
column (4.6 x 
250 nm) 
Acetonitrile-water 
gradient: 20:80 for the 
first 20 min followed 
by increase to 100% 
acetonitrile for the 
next 20 min. 
---- 
Pta and 
PtB at 
29.50 min 
20 µL 
220 nm 
260 nm 
+ 
75 µL of 1 N NaOH 
↓ 
1 h at 40°C 
↓ 
Add 0.76 µL of 5N HCl 
Jensen et 
al. 2008 
Agnew and Lauren 
method 
----- 
LC-MS 50 x 2.0 mm 
inner diameter, 3 
µm, Gemini C6-
hexyl 
40& CH3OH and 3 mM 
ammonium acetate 
0.2 
mL/min 
3.0 min 
for Pta 
and 10.0 
---- 
220 nm for PtB 
2690 LC Waters System 
LC-UV 214 nm for Pta 
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Reference Sample Cleaning Conversion of Pta to PtB 
Pta/PtB Quantification 
Equipment Column Mobile Phase 
Flow-
rate 
(mL/min) 
Retention 
Time 
Sample 
Injected 
Conditions 
Series 1100/1200 LC 
system with a diode array 
detector (DAD) 
Phenomenex® 
column 
min for 
Ptb 
Latorre 
2010 
--- 
25 mL filtrate + 1 mL 
NaOH 1 M 
--- 
Shim-pack ODS (4 
mm x 150 mm, 
Shimadzu) with 
safe guard 
column reverse 
phase C18 
H2O: CH3OH 
40% CH3OH (0-2 min) 
40-80% CH3OH (2-15 
min) 
80-40% CH3OH (15-16 
min) 
40 CH3OH (16-25 min) 
1 --- --- 
Pterosin B 
260 nm 
↓ 
2 h at 45 – 50 °C 
↓ 
3 x 10 mL of 
dichloromethane 
Fletcher 
et al. 
2011 
4 mL of filtrate was 
applied to a Fluka 
polyamide 6 column 
(0.45 g) (Sigma-Aldrich) 
1 mL of eluent + 75 µL/mL 
of NaOH 1 M 
--- 
Luna C18 column 
250 x 4.6 mm, 5 
µm 
The mobile phase was 
a mixture of (A) 40:60 
CH3CN in water (v/v) 
and (B) CH3CN with a 
gradient as follows: 09 
min, held at 100% A; 
911 min, 100% A100% 
B; 1116 min, held at 
100% B; 1616.5 min, 
100% B100% A; 16.525 
min, held at 100% A. 
1 
3.2 min 
for Pta 
and 11.1 
min for 
Ptb 
10 µL 
35 ºC 
220 nm 
↓ 
1 h at 40 °C 
↓ 
Add 75 µL/mL of H2SO4 2,5 
M 
Rasmussen 
et al. 
2013 
4 mL aqueous extract 
was passed through 
0.50 g resin (dry 
packed) on a 1.0 x 10 
cm I.D. glass Econo-
Column® (BIO-RAD) 
fitted with a 28 µm 
polymer filter 
Base-acid treatment 
Agilent 1100 Series HPLC 
system 
(G1314A VWD detector; 
G1312A Binary Pump; 
G1328A Manual Injector) 
Merck 
LiChroCART® 
column (125 x 4 
mm) packed with 
LiChrospher 100 
RP-8, 4 lm 
H2O: C2H3N (69:31, v/v) 1 
10.8 min 
Ptb 
500 µL 
Room temperature 
214 nm 
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B. Method Validation 
In this Appendix data related with the pterosin B quantification method validation is 
presented. 
B.1. Linearity Study 
Table 13 - Summary of linearity study. 
Theoretical Concentration 
(µg/mL)) 
Average peak area 
(mAU.min) 
Standard 
Deviation 
Relative Standard 
Deviation (%RSD) 
1 1.15 0.25 21.43 
5 3.35 0.28 8.49 
10 7.30 0.22 3.02 
25 15.53 0.28 1.82 
50 33.28 0.60 1.81 
80 59.94 0.80 1.40 
Y intercept -0.3841 
Slope 0.7009 
Correlation coefficient (R) 0.9985 
Coefficient of 
Determination (R2) 
0.9969 
Sa/a  2.78 % 
b-Sb -1.16 
b+Sb 0.40 
 
 
 
Figure 14 - Calibration Curve for Pterosin B (HPLC UV-Vis) at 220 nm. 
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B.2. Accuracy 
Table 14 - Accuracy results for different concentrations of Pterosin B. 
Theoretical Concentration 
(µg/mL) 
Mean Experimental 
Concentration (µg/mL) 
(n=3) 
Recovery (%) 
5.00 5.74 114.74 
25.00 24.99 99.97 
80.00 80.07 100.08 
Mean Recovery (%) 104.93 
% RSD 8.09 
 
B.3. Precision 
Table 15 - Results of precision determinations. 
Repeatability (Intra-day Precision) 
Concentration (µg/mL) SD %RSD 
1.00 0.04 7.53 
5.00 0.09 1.08 
10.00 0.42 4.70 
25.00 0.45 2.63 
50.00 0.95 1.80 
Intermediate Precision (Inter-day precision) 
1.00 0.03 5.57 
5.00 0.94 7.65 
10.00 0.45 4.84 
25.00 0.37 2.19 
50.00 1.04 1.96 
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C. NMR Data 
In this Appendix data regarding ptaquiloside and pterosin B NMR spectra are presented. 
Table 16 - 13C NMR data for pterosin B (DMSO) and for ptaquiloside (CH3OH). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Position 
δ 13C 
Pterosin B Ptaquiloside 
1 209.44 209.44 
2 41.85 41.85 
3 33.08 33.08 
4 152.07 152.07 
5 125.51 125.51 
6 144.05 144.05 
7 135.52 135.52 
8 136.44 136.44 
9 131.24 131.24 
10 16.18 16.18 
11 20.69 20.69 
12 31.86 31.86 
13 59.75 59.75 
14 13.04 13.04 
